SAN DIEGO, CA - Jun 17, 2015 - Parallel 6, an innovator in enterprise mobile engagement and management solutions, and Sentrian, the Remote Patient Intelligence company aspiring to eliminate all preventable hospitalization, announced today as technology partners, Clinical Reachs Reachlink Connector will send patient data securely from the palm of the patients hand to Sentrians remote patient monitoring platform (Sentrian RPI)
Parallel 6 and Sentrian together launch
mobile application for capturing patient self-report data
streams
SAN DIEGO, CA - Jun 17, 2015 - Parallel 6, an innovator in
enterprise mobile engagement and management solutions, and
Sentrian, the Remote Patient Intelligence company aspiring to
eliminate all preventable hospitalization, announced today as
technology partners, Clinical Reachs Reachlink Connector will send
patient data securely from the palm of the patients hand to
Sentrians remote patient monitoring platform (Sentrian RPI).
Parallel 6 will power Sentrian mobile applications to help care
teams better engage with chronic disease patients, turning patient
self-report data into another data input for the powerful Sentrian
analytics engine.
Clinical Reach is a HIPAA compliant, end-to-end patient
lifecycle management and engagement platform. Its ReachLink
Connectors ability to securely collect large amounts of patient
data in real-time via mobile and send through to the Sentrian RPI
platform will securely serve both patients and care teams in
multiple languages around the world.
As we combine our solution with Sentrians award winning RPI
platform, our technology changes the way patients and healthcare
providers evaluate their health, said CEO of Parallel 6, Allan
Camaisa. Our technologies are empowering people all over the world
to securely communicate.
Were always seeking to provide our care teams and
patients with the most effective interaction tools and platforms,
said Co-Founder, Chief Executive Officer of Sentrian, Dean Sawyer.
Together, were helping improve patient outcomes, reduce avoidable
costs and improve patient satisfaction for those dealing with
complex chronic disease.
Parallel 6 is an exhibitor at the DIA 2015 51st Annual Meeting
gathering in Washington, D.C. Booth #1957. Parallel 6 CEO and
Chairman, Allan Camaisa and President, CTO and Founder, David
Turner, will be available for interviews and a demo of their
technology platform. Please contact: Nikki Jimenez
nikki.jimenez@focuscominc.com 619-233-7778 to schedule a briefing
and/or interview.
###
About Parallel 6
Parallel 6, an innovator in enterprise cloud based technologies,
enables customer engagement and real-time data insights. Clinical
Reach, a Parallel 6 product, enables clinical trial stakeholders to
digitally recruit, eQualify, eConsent and engage clinical trial
participants through their patented platform. Additional solutions
include GovReach for Government Agencies and Captive Reach for
corporate organizations which desire to communicate via push
notifications, gamification strategies and more. The firm is
headquartered in San Diego with Federal offices in Washington D.C.
For more information, visit http://www.parallel6.com/
@Parallel6
About Sentrian
Sentrian, the first Remote Patient Intelligence company, aspires
to eliminate all preventable hospitalization by leveraging the
revolution in remote biosensors and machine learning to detect
patient deterioration early, before it becomes acute. Sentrians
value proposition to healthcare organizations is to provide a
cloud-based remote patient monitoring and analytics platform
intended to dramatically reduce preventable hospital admissions,
increase the efficiency and effectiveness of care teams and improve
quality metrics such as HEDIS and Star ratings. The Sentrian
platform is designed to seamlessly integrate with existing
healthcare information systems and clinical workflows, facilitating
adoption. Find us at http://sentrian.com/, on Twitter and
LinkedIn.